A big data breach and deepening financial woes have sparked new concerns about the 23andMe's ability to protect the personal ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

Doing so, it promises, will “terminate your relationship with 23andMe and irreversibly delete your account and Personal Information.” But there’s another clause in the email that conflicts w ...

Andre Fernandez, Jim Frankola and Mark Jensen will join the company's CEO Anne Wojcicki on the board. 23andMe appointed three ...

23andMe, a genetic-testing and ancestry-tracing company, collects the most personal kind of data from its customers: their DNA. Now, after a data breach in late 2023 and a full board resignation ...

Around a year ago, 23andMe had a data breach that led to 6.9 million profiles being accessible. Now, the company has agreed to pay a $30 million settlement after a class-action lawsuit was ...

If you're looking for thorough health information, go with 23andMe. Ancestry is the better option if you're looking for family members or chart your lineage. Thanks to its extensive DNA database ...

She has been working in journalism for seven years. David Paul Morris/Bloomberg/Getty For the last decade, 23andMe has been known worldwide for offering genetic testing, ancestry tracing and ...

Biotech company 23andMe was once hailed as one of the most successful businesses selling DNA analysis services to anybody who could afford one of its saliva test kits. But 18 years after it was ...

The company said Tuesday it has appointed Andre Fernandez, Jim Frankola and Mark Jensen as independent board members. The trio will serve on 23andMe's audit committee and compensation committee.

Anne Wojcicki wanted to run things—alone. It was 2009 and her startup 23andMe was riding high, fueled by a steady stream of venture money, intriguing personal accounts of genome exploration ...

23andMe has appointed three new independent directors to its board following the mass resignation of all seven of its previous members last month. The biotech company said in an SEC filing that ...